Skip to content

Bio-clinical Evolutive Dynamic in Patients Suffering From Communitary Septic Shock (Biosepsis)

Bio-clinical Evolutive Dynamic in Patients Suffering From Communitary Septic Shock (Biosepsis)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01668329
Acronym
BIOSEPSIS
Enrollment
64
Registered
2012-08-20
Start date
2009-09-30
Completion date
2012-10-31
Last updated
2015-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immunocompetent Patient on Septic Shock

Keywords

Septic shock, Inflammatory process, Cytokines, Hormonal response, Oxydative stress

Brief summary

Septic shock is a frequent pathology responsible for over 30000 deaths/year in France. Its outcome has not been improved despite the knowledge on inflammatory processes; a reason for these lack of results may lay on the lack of data on the precise dynamics of inflammatory and anti-inflammatory cascades and their consequences. We intend to achieve accurate monitoring of the inflammatory process on a small group of non-immunocompromised patients. Our goal is to obtain quality data, repeated over time, by limiting the technical variability.

Detailed description

The aim is to obtain precise data on the dynamics of cytokines, oxydative stress and hormonal response on immunocompetent adults during septic shock.

Interventions

None listed

Sponsors

University Hospital, Grenoble
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient over 18 years admitted in ICU. * Clinical evidence of infection, suspected or proved, during the 48hrs following the hospital entry. * Systemic inflammatory response syndrome. * Shock defined as arterial hypotension (\<90mmHg)not responding to adequated filling.

Exclusion criteria

* Minors * Patient under guardianship or trusteeship * Pregnant or lactating women * Not affiliated to the social security * Deprived of liberty by court decision * Patients hospitalised without their approval * Shock related to another cause than infection * Long term corticothérapy * On-going chemiothérapy, AIDS * Bedridden patient

Design outcomes

Primary

MeasureTime frame
Evolutive profile of the inflammatory response during septic shockHospitalisation in ICU

Secondary

MeasureTime frame
Research for early prognosis factorsHospitalisation in ICU

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026